Selected research
Industry Research
Probiotics for Middle-aged and Elderly Industry Research Report 2026
Market perspective
The global Probiotics for Middle-aged and Elderly market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Probiotics for Middle-aged and Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Probiotics for Middle-aged and Elderly is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Probiotics for Middle-aged and Elderly is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Probiotics for Middle-aged and Elderly include DuPont(Danisco), Chr. Hansen, China-Biotics, Nestle, Danone, BioGaia, OMNi-BiOTiC, Glory Biotech and Ganeden, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Probiotics for Middle-aged and Elderly market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Probiotics for Middle-aged and Elderly Market by Company
DuPont(Danisco)
Chr. Hansen
China-Biotics
Nestle
Danone
BioGaia
OMNi-BiOTiC
Glory Biotech
Ganeden
Morinaga Milk Industry
Sabinsa
Greentech
Bioriginal
Biosearch Life
UAS Laboratories
Synbiotech
Probiotics for Middle-aged and Elderly Segment by Type
Lactic Acid Bacteria
Bifidobacterium
Others
Probiotics for Middle-aged and Elderly Segment by Application
Supermarket
Online Retail
Others
Probiotics for Middle-aged and Elderly Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probiotics for Middle-aged and Elderly market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Probiotics for Middle-aged and Elderly and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probiotics for Middle-aged and Elderly.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Probiotics for Middle-aged and Elderly manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Probiotics for Middle-aged and Elderly by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Probiotics for Middle-aged and Elderly in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Probiotics for Middle-aged and Elderly Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Probiotics for Middle-aged and Elderly Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Probiotics for Middle-aged and Elderly Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Probiotics for Middle-aged and Elderly Revenue of Manufacturers (2021-2026)
Table 9. Global Probiotics for Middle-aged and Elderly Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Probiotics for Middle-aged and Elderly Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Probiotics for Middle-aged and Elderly Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Probiotics for Middle-aged and Elderly, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Probiotics for Middle-aged and Elderly, Product Type & Application
Table 14. Global Probiotics for Middle-aged and Elderly Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Probiotics for Middle-aged and Elderly by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. DuPont(Danisco) Company Information
Table 19. DuPont(Danisco) Business Overview
Table 20. DuPont(Danisco) Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. DuPont(Danisco) Probiotics for Middle-aged and Elderly Product Portfolio
Table 22. DuPont(Danisco) Recent Developments
Table 23. Chr. Hansen Company Information
Table 24. Chr. Hansen Business Overview
Table 25. Chr. Hansen Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Chr. Hansen Probiotics for Middle-aged and Elderly Product Portfolio
Table 27. Chr. Hansen Recent Developments
Table 28. China-Biotics Company Information
Table 29. China-Biotics Business Overview
Table 30. China-Biotics Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. China-Biotics Probiotics for Middle-aged and Elderly Product Portfolio
Table 32. China-Biotics Recent Developments
Table 33. Nestle Company Information
Table 34. Nestle Business Overview
Table 35. Nestle Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Nestle Probiotics for Middle-aged and Elderly Product Portfolio
Table 37. Nestle Recent Developments
Table 38. Danone Company Information
Table 39. Danone Business Overview
Table 40. Danone Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Danone Probiotics for Middle-aged and Elderly Product Portfolio
Table 42. Danone Recent Developments
Table 43. BioGaia Company Information
Table 44. BioGaia Business Overview
Table 45. BioGaia Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. BioGaia Probiotics for Middle-aged and Elderly Product Portfolio
Table 47. BioGaia Recent Developments
Table 48. OMNi-BiOTiC Company Information
Table 49. OMNi-BiOTiC Business Overview
Table 50. OMNi-BiOTiC Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. OMNi-BiOTiC Probiotics for Middle-aged and Elderly Product Portfolio
Table 52. OMNi-BiOTiC Recent Developments
Table 53. Glory Biotech Company Information
Table 54. Glory Biotech Business Overview
Table 55. Glory Biotech Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Glory Biotech Probiotics for Middle-aged and Elderly Product Portfolio
Table 57. Glory Biotech Recent Developments
Table 58. Ganeden Company Information
Table 59. Ganeden Business Overview
Table 60. Ganeden Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Ganeden Probiotics for Middle-aged and Elderly Product Portfolio
Table 62. Ganeden Recent Developments
Table 63. Morinaga Milk Industry Company Information
Table 64. Morinaga Milk Industry Business Overview
Table 65. Morinaga Milk Industry Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Morinaga Milk Industry Probiotics for Middle-aged and Elderly Product Portfolio
Table 67. Morinaga Milk Industry Recent Developments
Table 68. Sabinsa Company Information
Table 69. Sabinsa Business Overview
Table 70. Sabinsa Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Sabinsa Probiotics for Middle-aged and Elderly Product Portfolio
Table 72. Sabinsa Recent Developments
Table 73. Greentech Company Information
Table 74. Greentech Business Overview
Table 75. Greentech Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Greentech Probiotics for Middle-aged and Elderly Product Portfolio
Table 77. Greentech Recent Developments
Table 78. Bioriginal Company Information
Table 79. Bioriginal Business Overview
Table 80. Bioriginal Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Bioriginal Probiotics for Middle-aged and Elderly Product Portfolio
Table 82. Bioriginal Recent Developments
Table 83. Biosearch Life Company Information
Table 84. Biosearch Life Business Overview
Table 85. Biosearch Life Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. Biosearch Life Probiotics for Middle-aged and Elderly Product Portfolio
Table 87. Biosearch Life Recent Developments
Table 88. UAS Laboratories Company Information
Table 89. UAS Laboratories Business Overview
Table 90. UAS Laboratories Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. UAS Laboratories Probiotics for Middle-aged and Elderly Product Portfolio
Table 92. UAS Laboratories Recent Developments
Table 93. Synbiotech Company Information
Table 94. Synbiotech Business Overview
Table 95. Synbiotech Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Synbiotech Probiotics for Middle-aged and Elderly Product Portfolio
Table 97. Synbiotech Recent Developments
Table 98. Global Probiotics for Middle-aged and Elderly Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 99. Global Probiotics for Middle-aged and Elderly Sales by Region (2021-2026) & (k units)
Table 100. Global Probiotics for Middle-aged and Elderly Sales Market Share by Region (2021-2026)
Table 101. Global Probiotics for Middle-aged and Elderly Sales by Region (2027-2032) & (k units)
Table 102. Global Probiotics for Middle-aged and Elderly Sales Market Share by Region (2027-2032)
Table 103. Global Probiotics for Middle-aged and Elderly Revenue by Region (2021-2026) & (US$ Million)
Table 104. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Region (2021-2026)
Table 105. Global Probiotics for Middle-aged and Elderly Revenue by Region (2027-2032) & (US$ Million)
Table 106. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Region (2027-2032)
Table 107. North America Probiotics for Middle-aged and Elderly Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 108. North America Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units)
Table 109. North America Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units)
Table 110. North America Probiotics for Middle-aged and Elderly Revenue by Country (2021-2026) & (US$ Million)
Table 111. North America Probiotics for Middle-aged and Elderly Revenue by Country (2027-2032) & (US$ Million)
Table 112. Europe Probiotics for Middle-aged and Elderly Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. Europe Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units)
Table 114. Europe Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units)
Table 115. Europe Probiotics for Middle-aged and Elderly Revenue by Country (2021-2026) & (US$ Million)
Table 116. Europe Probiotics for Middle-aged and Elderly Revenue by Country (2027-2032) & (US$ Million)
Table 117. Asia Pacific Probiotics for Middle-aged and Elderly Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Asia Pacific Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units)
Table 119. Asia Pacific Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units)
Table 120. Asia Pacific Probiotics for Middle-aged and Elderly Revenue by Country (2021-2026) & (US$ Million)
Table 121. Asia Pacific Probiotics for Middle-aged and Elderly Revenue by Country (2027-2032) & (US$ Million)
Table 122. South America Probiotics for Middle-aged and Elderly Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. South America Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units)
Table 124. South America Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units)
Table 125. South America Probiotics for Middle-aged and Elderly Revenue by Country (2021-2026) & (US$ Million)
Table 126. South America Probiotics for Middle-aged and Elderly Revenue by Country (2027-2032) & (US$ Million)
Table 127. Middle East and Africa Probiotics for Middle-aged and Elderly Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. Middle East and Africa Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units)
Table 129. Middle East and Africa Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units)
Table 130. Middle East and Africa Probiotics for Middle-aged and Elderly Revenue by Country (2021-2026) & (US$ Million)
Table 131. Middle East and Africa Probiotics for Middle-aged and Elderly Revenue by Country (2027-2032) & (US$ Million)
Table 132. Global Probiotics for Middle-aged and Elderly Sales by Type (2021-2026) & (k units)
Table 133. Global Probiotics for Middle-aged and Elderly Sales by Type (2027-2032) & (k units)
Table 134. Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2021-2026)
Table 135. Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2027-2032)
Table 136. Global Probiotics for Middle-aged and Elderly Revenue by Type (2021-2026) & (US$ Million)
Table 137. Global Probiotics for Middle-aged and Elderly Revenue by Type (2027-2032) & (US$ Million)
Table 138. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2021-2026)
Table 139. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2027-2032)
Table 140. Global Probiotics for Middle-aged and Elderly Price by Type (2021-2026) & (USD/unit)
Table 141. Global Probiotics for Middle-aged and Elderly Price by Type (2027-2032) & (USD/unit)
Table 142. Global Probiotics for Middle-aged and Elderly Sales by Application (2021-2026) & (k units)
Table 143. Global Probiotics for Middle-aged and Elderly Sales by Application (2027-2032) & (k units)
Table 144. Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2021-2026)
Table 145. Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2027-2032)
Table 146. Global Probiotics for Middle-aged and Elderly Revenue by Application (2021-2026) & (US$ Million)
Table 147. Global Probiotics for Middle-aged and Elderly Revenue by Application (2027-2032) & (US$ Million)
Table 148. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2021-2026)
Table 149. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2027-2032)
Table 150. Global Probiotics for Middle-aged and Elderly Price by Application (2021-2026) & (USD/unit)
Table 151. Global Probiotics for Middle-aged and Elderly Price by Application (2027-2032) & (USD/unit)
Table 152. Key Raw Materials
Table 153. Raw Materials Key Suppliers
Table 154. Probiotics for Middle-aged and Elderly Distributors List
Table 155. Probiotics for Middle-aged and Elderly Customers List
Table 156. Probiotics for Middle-aged and Elderly Industry Trends
Table 157. Probiotics for Middle-aged and Elderly Industry Drivers
Table 158. Probiotics for Middle-aged and Elderly Industry Restraints
Table 159. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Probiotics for Middle-aged and Elderly Product Image
Figure 5. Global Probiotics for Middle-aged and Elderly Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Probiotics for Middle-aged and Elderly Market Size (2021-2032) & (US$ Million)
Figure 7. Global Probiotics for Middle-aged and Elderly Sales (2021-2032) & (k units)
Figure 8. Global Probiotics for Middle-aged and Elderly Average Price (USD/unit) & (2021-2032)
Figure 9. Lactic Acid Bacteria Product Image
Figure 10. Bifidobacterium Product Image
Figure 11. Others Product Image
Figure 12. Supermarket Product Image
Figure 13. Online Retail Product Image
Figure 14. Others Product Image
Figure 15. Global Probiotics for Middle-aged and Elderly Revenue Share by Manufacturers in 2025
Figure 16. Global Manufacturers of Probiotics for Middle-aged and Elderly, Manufacturing Sites & Headquarters
Figure 17. Global Top 5 and 10 Probiotics for Middle-aged and Elderly Players Market Share by Revenue in 2025
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Probiotics for Middle-aged and Elderly Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 20. Global Probiotics for Middle-aged and Elderly Sales by Region in 2025
Figure 21. Global Probiotics for Middle-aged and Elderly Revenue by Region in 2025
Figure 22. North America Probiotics for Middle-aged and Elderly Market Size by Country in 2025
Figure 23. North America Probiotics for Middle-aged and Elderly Sales Market Share by Country (2021-2032)
Figure 24. North America Probiotics for Middle-aged and Elderly Revenue Market Share by Country (2021-2032)
Figure 25. United States Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Canada Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Mexico Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Europe Probiotics for Middle-aged and Elderly Market Size by Country in 2025
Figure 29. Europe Probiotics for Middle-aged and Elderly Sales Market Share by Country (2021-2032)
Figure 30. Europe Probiotics for Middle-aged and Elderly Revenue Market Share by Country (2021-2032)
Figure 31. Germany Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. France Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. U.K. Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Italy Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Russia Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Spain Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Netherlands Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Switzerland Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Sweden Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Poland Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Asia Pacific Probiotics for Middle-aged and Elderly Market Size by Country in 2025
Figure 42. Asia Pacific Probiotics for Middle-aged and Elderly Sales Market Share by Country (2021-2032)
Figure 43. Asia Pacific Probiotics for Middle-aged and Elderly Revenue Market Share by Country (2021-2032)
Figure 44. China Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Japan Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South Korea Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. India Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Australia Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Taiwan Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. South America Probiotics for Middle-aged and Elderly Market Size by Country in 2025
Figure 53. South America Probiotics for Middle-aged and Elderly Sales Market Share by Country (2021-2032)
Figure 54. South America Probiotics for Middle-aged and Elderly Revenue Market Share by Country (2021-2032)
Figure 55. Brazil Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Argentina Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Chile Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Middle East and Africa Probiotics for Middle-aged and Elderly Market Size by Country in 2025
Figure 59. Middle East and Africa Probiotics for Middle-aged and Elderly Sales Market Share by Country (2021-2032)
Figure 60. Middle East and Africa Probiotics for Middle-aged and Elderly Revenue Market Share by Country (2021-2032)
Figure 61. Egypt Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. South Africa Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Israel Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Türkiye Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. GCC Countries Probiotics for Middle-aged and Elderly Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2021-2032)
Figure 67. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2021-2032)
Figure 68. Global Probiotics for Middle-aged and Elderly Price (USD/unit) by Type (2021-2032)
Figure 69. Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2021-2032)
Figure 70. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2021-2032)
Figure 71. Global Probiotics for Middle-aged and Elderly Price (USD/unit) by Application (2021-2032)
Figure 72. Probiotics for Middle-aged and Elderly Value Chain
Figure 73. Probiotics for Middle-aged and Elderly Production Mode & Process
Figure 74. Direct Comparison with Distribution Share
Figure 75. Distributors Profiles
Figure 76. Probiotics for Middle-aged and Elderly Industry Opportunities and Challenges
Scope & coverage.
Types
- Lactic Acid Bacteria
- Bifidobacterium
- Others
Applications
- Supermarket
- Online Retail
- Others
Companies covered
- DuPont(Danisco)
- Chr. Hansen
- China-Biotics
- Nestle
- Danone
- BioGaia
- OMNi-BiOTiC
- Glory Biotech
- Ganeden
- Morinaga Milk Industry
- Sabinsa
- Greentech
- Bioriginal
- Biosearch Life
- UAS Laboratories
- Synbiotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Probiotics for Middle-aged and Elderly Market Size (2021-2032)
- 2.2.2 Global Probiotics for Middle-aged and Elderly Sales (2021-2032)
- 2.2.3 Global Probiotics for Middle-aged and Elderly Market Average Price (2021-2032)
- 2.3 Probiotics for Middle-aged and Elderly by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Lactic Acid Bacteria
- 2.3.3 Bifidobacterium
- 2.3.4 Others
- 2.4 Probiotics for Middle-aged and Elderly by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Supermarket
- 2.4.3 Online Retail
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Probiotics for Middle-aged and Elderly Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Probiotics for Middle-aged and Elderly Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Probiotics for Middle-aged and Elderly Revenue of Manufacturers (2021-2026)
- 3.4 Global Probiotics for Middle-aged and Elderly Average Price by Manufacturers (2021-2026)
- 3.5 Global Probiotics for Middle-aged and Elderly Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Probiotics for Middle-aged and Elderly, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Probiotics for Middle-aged and Elderly, Product Type & Application
- 3.8 Global Manufacturers of Probiotics for Middle-aged and Elderly, Established Date
- 3.9 Global Probiotics for Middle-aged and Elderly Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 DuPont(Danisco)
- 4.1.1 DuPont(Danisco) Company Information
- 4.1.2 DuPont(Danisco) Business Overview
- 4.1.3 DuPont(Danisco) Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 DuPont(Danisco) Probiotics for Middle-aged and Elderly Product Portfolio
- 4.1.5 DuPont(Danisco) Recent Developments
- 4.2 Chr. Hansen
- 4.2.1 Chr. Hansen Company Information
- 4.2.2 Chr. Hansen Business Overview
- 4.2.3 Chr. Hansen Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Chr. Hansen Probiotics for Middle-aged and Elderly Product Portfolio
- 4.2.5 Chr. Hansen Recent Developments
- 4.3 China-Biotics
- 4.3.1 China-Biotics Company Information
- 4.3.2 China-Biotics Business Overview
- 4.3.3 China-Biotics Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 China-Biotics Probiotics for Middle-aged and Elderly Product Portfolio
- 4.3.5 China-Biotics Recent Developments
- 4.4 Nestle
- 4.4.1 Nestle Company Information
- 4.4.2 Nestle Business Overview
- 4.4.3 Nestle Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nestle Probiotics for Middle-aged and Elderly Product Portfolio
- 4.4.5 Nestle Recent Developments
- 4.5 Danone
- 4.5.1 Danone Company Information
- 4.5.2 Danone Business Overview
- 4.5.3 Danone Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Danone Probiotics for Middle-aged and Elderly Product Portfolio
- 4.5.5 Danone Recent Developments
- 4.6 BioGaia
- 4.6.1 BioGaia Company Information
- 4.6.2 BioGaia Business Overview
- 4.6.3 BioGaia Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BioGaia Probiotics for Middle-aged and Elderly Product Portfolio
- 4.6.5 BioGaia Recent Developments
- 4.7 OMNi-BiOTiC
- 4.7.1 OMNi-BiOTiC Company Information
- 4.7.2 OMNi-BiOTiC Business Overview
- 4.7.3 OMNi-BiOTiC Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 OMNi-BiOTiC Probiotics for Middle-aged and Elderly Product Portfolio
- 4.7.5 OMNi-BiOTiC Recent Developments
- 4.8 Glory Biotech
- 4.8.1 Glory Biotech Company Information
- 4.8.2 Glory Biotech Business Overview
- 4.8.3 Glory Biotech Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Glory Biotech Probiotics for Middle-aged and Elderly Product Portfolio
- 4.8.5 Glory Biotech Recent Developments
- 4.9 Ganeden
- 4.9.1 Ganeden Company Information
- 4.9.2 Ganeden Business Overview
- 4.9.3 Ganeden Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Ganeden Probiotics for Middle-aged and Elderly Product Portfolio
- 4.9.5 Ganeden Recent Developments
- 4.10 Morinaga Milk Industry
- 4.10.1 Morinaga Milk Industry Company Information
- 4.10.2 Morinaga Milk Industry Business Overview
- 4.10.3 Morinaga Milk Industry Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Morinaga Milk Industry Probiotics for Middle-aged and Elderly Product Portfolio
- 4.10.5 Morinaga Milk Industry Recent Developments
- 4.11 Sabinsa
- 4.11.1 Sabinsa Company Information
- 4.11.2 Sabinsa Business Overview
- 4.11.3 Sabinsa Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sabinsa Probiotics for Middle-aged and Elderly Product Portfolio
- 4.11.5 Sabinsa Recent Developments
- 4.12 Greentech
- 4.12.1 Greentech Company Information
- 4.12.2 Greentech Business Overview
- 4.12.3 Greentech Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Greentech Probiotics for Middle-aged and Elderly Product Portfolio
- 4.12.5 Greentech Recent Developments
- 4.13 Bioriginal
- 4.13.1 Bioriginal Company Information
- 4.13.2 Bioriginal Business Overview
- 4.13.3 Bioriginal Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Bioriginal Probiotics for Middle-aged and Elderly Product Portfolio
- 4.13.5 Bioriginal Recent Developments
- 4.14 Biosearch Life
- 4.14.1 Biosearch Life Company Information
- 4.14.2 Biosearch Life Business Overview
- 4.14.3 Biosearch Life Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Biosearch Life Probiotics for Middle-aged and Elderly Product Portfolio
- 4.14.5 Biosearch Life Recent Developments
- 4.15 UAS Laboratories
- 4.15.1 UAS Laboratories Company Information
- 4.15.2 UAS Laboratories Business Overview
- 4.15.3 UAS Laboratories Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 UAS Laboratories Probiotics for Middle-aged and Elderly Product Portfolio
- 4.15.5 UAS Laboratories Recent Developments
- 4.16 Synbiotech
- 4.16.1 Synbiotech Company Information
- 4.16.2 Synbiotech Business Overview
- 4.16.3 Synbiotech Probiotics for Middle-aged and Elderly Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Synbiotech Probiotics for Middle-aged and Elderly Product Portfolio
- 4.16.5 Synbiotech Recent Developments
5 Global Probiotics for Middle-aged and Elderly Market Scenario by Region
- 5.1 Global Probiotics for Middle-aged and Elderly Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Probiotics for Middle-aged and Elderly Sales by Region: 2021-2032
- 5.2.1 Global Probiotics for Middle-aged and Elderly Sales by Region: 2021-2026
- 5.2.2 Global Probiotics for Middle-aged and Elderly Sales by Region: 2027-2032
- 5.3 Global Probiotics for Middle-aged and Elderly Revenue by Region: 2021-2032
- 5.3.1 Global Probiotics for Middle-aged and Elderly Revenue by Region: 2021-2026
- 5.3.2 Global Probiotics for Middle-aged and Elderly Revenue by Region: 2027-2032
- 5.4 North America Probiotics for Middle-aged and Elderly Market Facts & Figures by Country
- 5.4.1 North America Probiotics for Middle-aged and Elderly Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Probiotics for Middle-aged and Elderly Sales by Country (2021-2032)
- 5.4.3 North America Probiotics for Middle-aged and Elderly Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Probiotics for Middle-aged and Elderly Market Facts & Figures by Country
- 5.5.1 Europe Probiotics for Middle-aged and Elderly Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Probiotics for Middle-aged and Elderly Sales by Country (2021-2032)
- 5.5.3 Europe Probiotics for Middle-aged and Elderly Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Probiotics for Middle-aged and Elderly Market Facts & Figures by Country
- 5.6.1 Asia Pacific Probiotics for Middle-aged and Elderly Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Probiotics for Middle-aged and Elderly Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Probiotics for Middle-aged and Elderly Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Probiotics for Middle-aged and Elderly Market Facts & Figures by Country
- 5.7.1 South America Probiotics for Middle-aged and Elderly Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Probiotics for Middle-aged and Elderly Sales by Country (2021-2032)
- 5.7.3 South America Probiotics for Middle-aged and Elderly Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Probiotics for Middle-aged and Elderly Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Probiotics for Middle-aged and Elderly Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Probiotics for Middle-aged and Elderly Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Probiotics for Middle-aged and Elderly Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Probiotics for Middle-aged and Elderly Sales by Type (2021-2032)
- 6.1.1 Global Probiotics for Middle-aged and Elderly Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2021-2032)
- 6.2 Global Probiotics for Middle-aged and Elderly Revenue by Type (2021-2032)
- 6.2.1 Global Probiotics for Middle-aged and Elderly Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2021-2032)
- 6.3 Global Probiotics for Middle-aged and Elderly Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Probiotics for Middle-aged and Elderly Sales by Application (2021-2032)
- 7.1.1 Global Probiotics for Middle-aged and Elderly Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2021-2032)
- 7.2 Global Probiotics for Middle-aged and Elderly Revenue by Application (2021-2032)
- 7.2.1 Global Probiotics for Middle-aged and Elderly Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2021-2032)
- 7.3 Global Probiotics for Middle-aged and Elderly Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Probiotics for Middle-aged and Elderly Value Chain Analysis
- 8.1.1 Probiotics for Middle-aged and Elderly Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Probiotics for Middle-aged and Elderly Production Mode & Process
- 8.2 Probiotics for Middle-aged and Elderly Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Probiotics for Middle-aged and Elderly Distributors
- 8.2.3 Probiotics for Middle-aged and Elderly Customers
9 Global Probiotics for Middle-aged and Elderly Analyzing Market Dynamics
- 9.1 Probiotics for Middle-aged and Elderly Industry Trends
- 9.2 Probiotics for Middle-aged and Elderly Industry Drivers
- 9.3 Probiotics for Middle-aged and Elderly Industry Opportunities and Challenges
- 9.4 Probiotics for Middle-aged and Elderly Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst